Familial Longevity Is Marked by Better Cognitive Performance at Middle Age: The Leiden Longevity Study

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Stijntjes, Marjon ^a,b,c   de Craen, Anton J M ^a,c   van Heemst, Diana ^a,c   Meskers, Carel G M ^a   van Buchem, Mark A ^a,c   Westendorp, Rudi G J ^a,c,d   Slagboom, P Eline ^a,c   Maier, Andrea B ^a,b,c  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Netherlands Consortium for Healthy Ageing   (Netherlands)

^d Leyden Academy on Vitality and Ageing   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; AUTACOID;

15 PICTURE LEARNING TEST; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; ATTENTION; CARDIOVASCULAR DISEASE; COGNITION; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIGIT SYMBOL SUBSTITUTION TEST; EDUCATION; FAMILY HISTORY; FEMALE; GENDER; GENOTYPE; HUMAN; HUMAN EXPERIMENT; LONGEVITY; LONGITUDINAL STUDY; MALE; MEMORY; MIDDLE AGED; NORMAL HUMAN; PROGENY; PSYCHOLOGIC TEST; SMOKING; STROOP TEST;

AGED; COGNITION; FAMILY; FEMALE; HUMANS; LONGEVITY; MALE; MIDDLE AGED; NETHERLANDS; SIBLINGS; STROOP TEST;

EID: 84874628558     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057962     Document Type: Article

References (30)

1. Singh-Manoux A, Kivimaki M, Glymour MM, Elbaz A, Berr C, et al. (2012) Timing of onset of cognitive decline: results from Whitehall II prospective cohort study. BMJ 344: 7622-7630.
2. Ronnlund M, Nyberg L, Backman L, Nilsson LG, (2005) Stability, growth, and decline in adult life span development of declarative memory: cross-sectional and longitudinal data from a population-based study. Psychol Aging 20: 3-18.
3. Nilsson LG, Sternang O, Ronnlund M, Nyberg L, (2009) Challenging the notion of an early-onset of cognitive decline. Neurobiol Aging 30: 521-524.
4. Salthouse TA, (2009) When does age-related cognitive decline begin? Neurobiol Aging 30: 507-514.
5. Marshall RS, Lazar RM, (2011) Pumps, aqueducts, and drought management: vascular physiology in vascular cognitive impairment. Stroke 42: 221-226.
6. Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, et al. (2011) Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke 42: 2672-2713.
7. Bennett SJ, Sauve MJ, (2003) Cognitive deficits in patients with heart failure: a review of the literature. J Cardiovasc Nurs 18: 219-242.
8. Beeri MS, Ravona-Springer R, Silverman JM, Haroutunian V, (2009) The effects of cardiovascular risk factors on cognitive compromise. Dialogues Clin Neurosci 11: 201-212.
9. Whitmer RA, Sidney S, Selby J, Johnston SC, Yaffe K, (2005) Midlife cardiovascular risk factors and risk of dementia in late life. Neurology 64: 277-281.
10. Cukierman T, Gerstein HC, Williamson JD, (2005) Cognitive decline and dementia in diabetes-systematic overview of prospective observational studies. Diabetologia 48: 2460-2469.
11. Campbell IL, Stalder AK, Chiang CS, Bellinger R, Heyser CJ, et al. (1997) Transgenic models to assess the pathogenic actions of cytokines in the central nervous system. Mol Psychiatry 2: 125-129.
12. Eikelenboom P, Veerhuis R, (1999) The importance of inflammatory mechanisms for the development of Alzheimer's disease. Exp Gerontol 34: 453-461.
13. Marengoni A, Fratiglioni L, Bandinelli S, Ferrucci L, (2011) Socioeconomic status during lifetime and cognitive impairment no-dementia in late life: the population-based aging in the Chianti Area (InCHIANTI) Study. J Alzheimers Dis 24: 559-568.
14. Koster A, Penninx BW, Bosma H, Kempen GI, Newman AB, et al. (2005) Socioeconomic differences in cognitive decline and the role of biomedical factors. Ann Epidemiol 15: 564-571.
15. Basta NE, Matthews FE, Chatfield MD, Brayne C, (2008) Community-level socio-economic status and cognitive and functional impairment in the older population. Eur J Public Health 18: 48-54.
16. Henderson AS, Easteal S, Jorm AF, Mackinnon AJ, Korten AE, et al. (1995) Apolipoprotein E allele epsilon 4, dementia, and cognitive decline in a population sample. Lancet 346: 1387-1390.
17. Raber J, Huang Y, Ashford JW, (2004) ApoE genotype accounts for the vast majority of AD risk and AD pathology. Neurobiol Aging 25: 641-650.
18. Westendorp RG, van Heemst D, Rozing MP, Frolich M, Mooijaart SP, et al. (2009) Nonagenarian siblings and their offspring display lower risk of mortality and morbidity than sporadic nonagenarians: The Leiden Longevity Study. J Am Geriatr Soc 57: 1634-1637.
19. Waaijer ME, Gunn DA, Catt SD, van GM, de Craen AJ, et al. (2012) Morphometric skin characteristics dependent on chronological and biological age: the Leiden Longevity Study. Age (Dordr) 34: 1543-1552.
20. Borkan GA, Norris AH, (1980) Assessment of biological age using a profile of physical parameters. J Gerontol 35: 177-184.
21. Schoenmaker M, de Craen AJ, de Meijer PH, Beekman M, Blauw GJ, et al. (2006) Evidence of genetic enrichment for exceptional survival using a family approach: the Leiden Longevity Study. Eur J Hum Genet 14: 79-84.
22. Stroop JR, (1935) Studies of interference in serial verbal reactions. J Exp Psychol 121: 15-23.
23. Rozing MP, Mooijaart SP, Beekman M, Wijsman CA, Maier AB, et al. (2011) C-reactive protein and glucose regulation in familial longevity. Age (Dordr) 33: 623-630.
24. Deelen J, Beekman M, Uh HW, Helmer Q, Kuningas M, et al. (2011) Genome-wide association study identifies a single major locus contributing to survival into old age; the APOE locus revisited. Aging Cell 10: 686-698.
25. Christensen K, Johnson TE, Vaupel JW, (2006) The quest for genetic determinants of human longevity: challenges and insights. Nat Rev Genet 7: 436-448.
26. Schachter F, Faure-Delanef L, Guenot F, Rouger H, Froguel P, et al. (1994) Genetic associations with human longevity at the APOE and ACE loci. Nat Genet 6: 29-32.
27. Wijsman CA, Rozing MP, Streefland TC, le CS, Mooijaart SP, et al. (2011) Familial longevity is marked by enhanced insulin sensitivity. Aging Cell 10: 114-121.
28. Dekker P, Maier AB, van HD, de Koning-Treurniet C, Blom J, et al. (2009) Stress-induced responses of human skin fibroblasts in vitro reflect human longevity. Aging Cell 8: 595-603.
29. Derhovanessian E, Maier AB, Beck R, Jahn G, Hahnel K, et al. (2010) Hallmark features of immunosenescence are absent in familial longevity. J Immunol 185: 4618-4624.
30. Altmann-Schneider I, van der Grond J, Slagboom PE, Westendorp RG, Maier AB, et al. (2013) Lower susceptibility to cerebral small vessel disease in human familial longevity: the leiden longevity study. Stroke 44: 9-14.